Harender Kumar | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Harender Kumar | Neuroscience | Best Researcher AwardĀ šŸ†

Research Scholar at Panjab University Chandigarh, India.

Harender Kumar, a Research Scholar at Panjab University, Chandigarh, specializes in behavioral neuroscience. His work primarily focuses on investigating the relationship between diet, gut health, and stress resilience using zebrafish as a model organism. Kumar has published three notable journal articles in SCI/Scopus-indexed journals, with impactful contributions to neuroscience and chemistry. His research demonstrates a promising ability to bridge fundamental science with potential real-world applications.

Profile

Scopus

Education šŸŽ“:

Harender Kumar is pursuing his Ph.D. at Panjab University, Chandigarh, focusing on behavioral neuroscience. His academic journey reflects his dedication to understanding the complex interplay between biological systems and mental health. Harender’s educational background has provided a strong foundation in neuroscience, biology, and chemistry, enabling him to engage in cutting-edge research. At Panjab University, he has honed his expertise in experimental design, data analysis, and interdisciplinary collaboration, contributing significantly to his academic and professional growth. Through his education, Harender has developed a keen interest in the gut-brain axis, stress mechanisms, and the therapeutic potential of dietary interventions, preparing him for a promising career in research and innovation.

Work Experience šŸ’¼:

Harender Kumar has significant experience in behavioral neuroscience research, with a focus on gut-brain interactions and stress resilience. As a Research Scholar at Panjab University, he has conducted innovative studies using zebrafish models, exploring how dietary components influence mental health. Harender has collaborated with experts in chemistry to address diverse scientific challenges, such as detecting chemical agents and understanding synaptic remodeling. His hands-on expertise includes experimental planning, animal model studies, and data interpretation, which have resulted in publications in SCI/Scopus-indexed journals. Harender’s multidisciplinary experience reflects his ability to navigate complex scientific questions and contribute meaningfully to neuroscience and beyond.

Awards and Honors

Though specific awards and honors are not mentioned in the profile, Harender Kumarā€™s accomplishments in publishing high-quality research in reputable journals demonstrate academic recognition. His work has contributed to advancing behavioral neuroscience and interdisciplinary science. Securing awards such as research grants, best paper accolades, or conference presentations would further highlight his achievements and scholarly impact.

Research Interests:

Harender Kumar’s research centers on behavioral neuroscience, with an emphasis on understanding the gut-brain axis and its role in stress resilience. Using zebrafish as a model organism, he investigates the link between dietary factors and mental well-being, providing insights into potential therapeutic strategies. His multidisciplinary work integrates neuroscience, physiology, and chemistry, addressing critical issues such as synaptic remodeling and the stress-resilient effects of dietary interventions. Harenderā€™s innovative approach has contributed to a deeper understanding of mental health challenges and opened avenues for novel dietary strategies to enhance emotional resilience.

šŸ“š PublicationsĀ 

Stress-resilient Effect of Spirulina platensis on Zebrafish Chronic Unpredictable Stress Model

Authors: Kumar, H., Kaur, K., Kaur, R.

Journal: Physiology & Behavior

Year: 2024

Citations: 0

Role of Spirulina in Structural Remodeling of Synapse in Telencephalon of Chronic Unpredictable Stress Model of Zebrafish

Authors: Kumar, H., Garg, V., Kaur, K., Kaur, R.

Journal: Annals of Neurosciences

Year: 2023

Citations: 0

Synthesis of a Trinuclear Zinc(II) Cluster Composed of [4.4.3.01,5]Tridecane Cages: A Rapid Detection and Degradation Probe for the Chemical Warfare Agent Simulant Diethyl Cyanophosphonate in Protein-rich Food Products

Authors: Thakur, S., Rohilla, J., Kumar, K., Kumar, H., Singh, R., Kaur, V., Kamboj, R.

Journal: Analyst

Year: 2023

Citations: 4

ConclusionĀ 

Harender Kumar exhibits strong potential as a researcher in behavioral neuroscience, with impactful publications and an innovative focus on the gut-brain axis. While his current portfolio demonstrates high-quality research and interdisciplinary collaboration, there is room to enhance his profile by securing funded projects, expanding his professional engagement, and increasing the impact of his work through broader dissemination and applications. Overall, Harender is a commendable candidate for the Best Researcher Award, particularly for early-career recognition.

 

 

Amir Hossein Zarifkar | Neuroscience | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Amir Hossein Zarifkar | Neuroscience | Best Researcher Award šŸ†

Faculty member at Larestan University of Medical Sciences, Iran.

Dr. Amir Hossein Zarifkar is a dedicated researcher in the field of neurophysiology, specializing in Alzheimer’s disease models, memory impairment, and the effects of transcranial electrical stimulation. He holds a Ph.D. in Physiology, and his expertise includes stereotaxic surgery, cognitive testing, and advanced biochemical and histological techniques. His research contributions are evidenced by peer-reviewed publications, prestigious awards, and active participation in scientific conferences. As a teacher, he has guided students across multiple disciplines in physiology, further demonstrating his commitment to academia.

Profile

Scopus

Google Scholar

Education šŸŽ“:

Dr. Zarifkarā€™s academic journey began with a B.Sc. in Biology from Shiraz University, Iran (2010), where he laid the foundation for his passion in life sciences. He pursued his M.Sc. in Physiology at Ahvaz University of Medical Sciences (2014), conducting a thesis on the protective effects of agmatine in memory impairment models. Building upon this expertise, Dr. Zarifkar earned a Ph.D. in Physiology from Shiraz University of Medical Sciences (2019). His doctoral research, titled ā€œInvestigating the effect of transcranial electrical stimulation (tES) paradigms on beta-amyloid-induced memory impairment and hippocampal CA1 structural changes in male rats,ā€ received critical acclaim for its innovative approach to addressing Alzheimer’s disease. Throughout his education, Dr. Zarifkar consistently ranked among the top of his cohort, achieving first rank in the national Ph.D. entrance exam and being honored as a top student at Shiraz University of Medical Sciences.

Work Experience šŸ’¼:

Dr. Zarifkar has over a decade of experience in teaching, research, and experimental neurophysiology. As an educator, he delivers comprehensive courses in nervous system, kidney, gastrointestinal, and endocrine physiology to students in medicine, dentistry, pharmacy, and nursing. His hands-on laboratory sessions emphasize practical applications of physiology, fostering a deeper understanding among students. On the research front, Dr. Zarifkar specializes in Alzheimerā€™s disease, memory impairment, and innovative therapeutic approaches, utilizing advanced methodologies such as transcranial electrical stimulation, immunohistochemistry, and stereotaxic surgery. His expertise extends to conducting behavioral and cognitive experiments in animal models. Dr. Zarifkarā€™s findings have been presented at national and international conferences, enhancing the global understanding of neurodegenerative diseases. As a member of Iranā€™s National Elites Foundation, he actively contributes to academic and research communities, solidifying his role as a leader in the field of neurophysiology.

Awards and Honors šŸ†

Dr. Zarifkar has received multiple awards and recognitions for his academic excellence and contributions to neuroscience. Notably, he ranked first in the national Ph.D. entrance exam in Physiology, demonstrating his exceptional knowledge in the field. During his M.Sc. and Ph.D. studies, he was honored as a top student at Shiraz University of Medical Sciences. His groundbreaking research on Alzheimerā€™s disease earned him accolades at national and international scientific conferences. Dr. Zarifkar is also a proud member of Iranā€™s National Elites Foundation, a prestigious acknowledgment of his academic and research achievements. His dedication to teaching and mentoring has further earned him the respect and admiration of his peers and students alike. These honors reflect Dr. Zarifkarā€™s unwavering commitment to advancing the field of physiology and contributing to the understanding and treatment of neurodegenerative disorders.

Research Interests:

Dr. Zarifkarā€™s research centers on understanding the mechanisms underlying neurodegenerative diseases, particularly Alzheimerā€™s disease, and developing innovative therapeutic strategies. His Ph.D. work investigated the effects of transcranial electrical stimulation (tES) on memory impairment and structural changes in the hippocampus, providing insights into non-invasive treatments for Alzheimerā€™s. Dr. Zarifkarā€™s expertise extends to studying the impact of neuroprotective agents like agmatine on cognitive functions and neural plasticity. He employs advanced methodologies, including behavioral and cognitive assessments in animal models, immunohistochemistry, Western blot analysis, and stereotaxic surgery, to unravel the complexities of memory impairment. His findings contribute to a better understanding of the pathophysiology of neurodegenerative disorders and pave the way for potential clinical applications. By bridging experimental neuroscience with translational research, Dr. Zarifkar aims to develop effective interventions for enhancing cognitive health and mitigating the effects of aging-related neurological conditions.

šŸ“š PublicationsĀ 

Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis, and Akt/GSK3Ī² signaling disruption

Authors: M. Moosavi, A.H. Zarifkar, Y. Farbood, M. Dianat, A. Sarkaki, R. Ghasemi

Citations: 46

Year: 2014

Treatment with edaravone improves the structure and functional changes in the hippocampus after chronic cerebral hypoperfusion in rats

Authors: G.H. Meftahi, M. Bayat, A.H. Zarifkar, S. Akbari, A.B. Haghighi, M. Naseh

Citations: 18

Year: 2021

Ameliorative effects of different transcranial electrical stimulation paradigms on the novel object recognition task in a rat model of Alzheimer disease

Authors: A.H. Zarifkar, A. Zarifkar, M. Nami, A. Rafati, H. Aligholi, F. Vafaee

Citations: 12

Year: 2019

Effect of recombinant insulin-like growth factor-2 injected into the hippocampus on memory impairment following hippocampal intracerebral hemorrhage in rats

Authors: F. Vafaee, A. Zarifkar, M. Emamghoreishi, M.R. Namavar, M. Shahpari

Citations: 10

Year: 2018

Interactive Effects of Swimming High-Intensity Interval Training and Resveratrol Supplementation Improve Mitochondrial Protein Levels in the Hippocampus of Aged Rats

Authors: M. Amirazodi, F. Daryanoosh, A. Mehrabi, A. Gaeini, M. Koushkie Jahromi

Citations: 6

Year: 2022

The Comparison of the Effects of Different Transcranial Electrical Stimulation (tES) Paradigms on Beta-Amyloid (AĪ² 25ā€“35)-Induced Memory Impairment upon Morris Water Maze Task

Authors: A.H. Zarifkar, A. Zarifkar, M. Nami, A. Rafati, H. Aligholi

Citations: 5

Year: 2018

Different paradigms of transcranial electrical stimulation improve motor function impairment and striatum tissue injuries in the collagenase-induced intracerebral hemorrhage model

Authors: A.R. Heidarzadegan, A. Zarifkar, N. Sotoudeh, M.R. Namavar, A.H. Zarifkar

Citations: 4

Year: 2022

The protective effect of agmatine against intracerebroventricular streptozotocin-induced memory impairment in male rats

Authors: Y. Farbood, A.H. Zarifkar, M. Dianat, A. Sarkaki, M. Moosavi

Citations: 1

Year: 2014

Resistance Training and Resveratrol Supplementation Improve Cancer Cachexia and Tumor Volume in Muscle Tissue of Male Mice Bearing Colon Cancer CT26 Cell Tumors

Authors: M. Samadi, F. Daryanoosh, Z. Mojtahedi, A. Samsamy Pour, H. Nobari

Citations: Not yet cited

Year: 2024

Alterations in FoxO3a, NF-ĪŗB, and MuRF1 Expression in the Soleus Muscle of Male Rats Following High-Intensity Interval Training and Detraining

Authors: S. Sheibani, F. Daryanoosh, A.H. Zarifkar

Citations: Not yet cited

Year: 2024

Different paradigms of transcranial electrical stimulation induce structural changes in the CA1 region of the hippocampus in a rat model of Alzheimerā€™s disease

Authors: A.H. Zarifkar, A. Zarifkar, S. Safaei

Citations: Not yet cited

Year: 2024

P62: Agmatine Protects Against Intracerebroventricular Streptozotocin-Induced Water Maze Memory Deficit, Hippocampal Apoptosis and Akt/GSK3Ī² Signaling Disruption

Authors: M. Moosavi, A.H. Zarifkar, Y. Farbood, M. Dianat, A. Sarkaki, R. Ghasemi

Citations: Not listed

Year: 2018

ConclusionĀ 

Dr. Amir Hossein Zarifkar demonstrates an exceptional commitment to advancing neurophysiology research and teaching. His strengths, including rigorous experimental skills, teaching proficiency, and recognized achievements, position him as a strong candidate for a Best Researcher Award. Addressing areas like international visibility, grant acquisition, and translational focus could further strengthen his profile. Overall, his impactful contributions to Alzheimer’s research and academic excellence make him a deserving nominee.

 

 

Hee-Cheol Kim | Physiology | Best Researcher Award-duplicate-1

Posted on by sciencefather

Prof. Dr. Hee-Cheol Kim | Neuroscience | Best Researcher Award

Professor at Keimyung University School of Medicine, South Korea.

Dr. Hee-Cheol Kim is a seasoned psychiatrist and researcher with over three decades of academic, clinical, and administrative experience. His extensive body of work focuses on neurodegenerative diseases, mental health, type 2 diabetes, and the application of electroconvulsive therapy (ECT). His contributions include numerous publications in reputable journals, a history of leadership roles, and impactful research collaborations.

Profile

Orcid

 

Education šŸŽ“:

Dr. Hee-Cheol Kim began his medical education at Keimyung University School of Medicine, earning his M.D. in 1988. He pursued advanced research in psychiatry, completing his Ph.D. in 2001 at Kyungpook National University. His postgraduate training included a rotating internship and residency in psychiatry at Keimyung University Dongsan Medical Center, solidifying his expertise in mental health care. Dr. Kim’s commitment to global learning led him to New York University School of Medicine, where he served as a visiting professor at the Aging and Dementia Research Center. His multidisciplinary academic foundation and international exposure underpin his innovative contributions to psychiatry and neuropsychiatric research.

Work Experience šŸ’¼:

Dr. Hee-Cheol Kimā€™s career spans academic, clinical, and administrative roles. Since 1996, he has been affiliated with Keimyung University School of Medicine, rising from lecturer to professor. He held prestigious positions, including Dean of the School of Medicine and Vice President of Keimyung University Dongsan Hospital. His administrative expertise extends to directing medical affairs and mental health centers in South Korea. Dr. Kim also led the Keimyung University Brain Research Institute, driving advancements in neuroscience. Internationally, he served as a visiting professor at NYU, where he contributed to dementia research. His leadership, combined with his dedication to patient care and teaching, has made him a pillar in the psychiatric community.

Awards and HonorsĀ šŸ†

Dr. Hee-Cheol Kim has received numerous accolades for his contributions to psychiatry and medical education. His groundbreaking research in dementia, mental health, and neurodegenerative diseases has earned him recognition within the academic and medical communities. Dr. Kim has been honored by prestigious organizations, including the Korean Neuropsychiatric Association and the Korean Society for Affective Disorders. His leadership in psychiatry education has also been acknowledged through awards for his excellence in teaching and mentorship. As a member of multiple national and international psychiatric organizations, he has been celebrated for his dedication to advancing mental health care and fostering interdisciplinary collaborations in research and clinical practice.

Research Interests:

Dr. Hee-Cheol Kimā€™s research is centered on neuropsychiatry, focusing on dementia, neurodegenerative diseases, and the intersection of mental health with chronic medical conditions like type 2 diabetes. He is a pioneer in using electroconvulsive therapy (ECT) for treatment-resistant psychiatric disorders and neurodevelopmental challenges. His studies explore how conditions such as depression and Alzheimerā€™s influence comorbidities, providing critical insights into geriatric mental health. During his tenure at NYU, he contributed to dementia research, emphasizing early diagnosis and interventions. Dr. Kimā€™s recent work includes investigating the impact of COVID-19 on mental health and the association between chronic diseases and neurodegeneration. His research bridges clinical practice and academia, offering innovative solutions to improve patient outcomes and enhance mental health care.

šŸ“š PublicationsĀ 

  • “Risk of dementia in patients with ageā€related medical conditions: a retrospective cohort study”
    • Authors: Not specified in accessible sources.
    • Published in: Psychogeriatrics
    • Year: 2024
    • DOI: 10.1111/psyg.13222
  • “Impact of COVID-19 on the development of major mental disorders in patients visiting a university hospital: a retrospective observational study”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Yeungnam Medical Science
    • Year: 2024
    • DOI: 10.12701/jyms.2023.01256
  • “Effectiveness and Tolerability of Combination Pharmacotherapy With Stimulant and Non-Stimulant in Children With Attention Deficit Hyperactivity Disorder”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of the Korean Academy of Child and Adolescent Psychiatry
    • Year: 2024
    • DOI: 10.5765/jkacap.230048
  • “Risk of Neurodegenerative Diseases in Elderly Koreans with an Initial Diagnosis of Type 2 Diabetes: A Nationwide Retrospective Cohort Study”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Diabetes Research
    • Year: 2023
    • DOI: 10.1155/2023/7887792
  • “The Association Between Cancer and Neurodegenerative Diseases: A Retrospective Cohort Study Using the National Health Insurance Service-National Health Information Database”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Korean Neuropsychiatric Association
    • Year: 2021
    • DOI: 10.4306/jknpa.2021.60.4.307

ConclusionĀ 

Dr. Hee-Cheol Kim stands out as a compelling candidate for the Best Researcher Award due to his prolific academic record, innovative contributions to psychiatry, and significant influence on mental health practices in Korea and beyond. His career demonstrates a harmonious blend of research, teaching, and leadership, making him an exemplary figure in the field. Strengthening interdisciplinary collaborations and expanding his international footprint would further cement his legacy as a leading researcher.

 

Hristina Čolović | Neuroscience | Robotics Integration Award

Posted on by sciencefather

Prof. Dr. Hristina Čolović | Neuroscience | Robotics Integration Award

spec.Physical Medicine and Rehabilitation at University of Nis, Faculty of Medicine, Serbia 2 Physical Medicine and Rehabilitation Clinic, Clinical Center of Nis, Serbia, SerbiašŸŽ“

Dr. Hristina Čolović is an accomplished Physiatrist specializing in physical medicine and rehabilitation, with a particular focus on pediatric rehabilitation and the use of botulinum toxin in treating spasticity in children with cerebral palsy. With a robust academic background, including a PhD in Physical Medicine and Rehabilitation, she has made significant contributions to the field, especially in robotic neurorehabilitation after pediatric stroke. She is actively involved in clinical practice, research, and teaching, and has a record of publications in notable scientific journals.

 

ProfileĀ 

Scopus

Education šŸŽ“:

Dr. Hristina Čolović completed her undergraduate studies at the Faculty of Medicine, University of Nis, Serbia, in 1992, with a distinguished average grade of 9.06. She pursued specialization in Physical Medicine and Rehabilitation at the same institution, receiving excellent grades (5/5) in 1998. Dr. Čolović furthered her expertise with a subspecialization in Pediatric Rehabilitation from the Faculty of Medicine, University of Belgrade, in 2007, earning another top grade. She completed her Ph.D. in 2012, focusing on the effects of Botulinum toxin type A in the habilitation of children with cerebral palsy. Her academic foundation and continuing education have provided a solid basis for her leadership in both clinical practice and research. Dr. Čolović’s ongoing commitment to academic development is reflected in her teaching roles, where she lectures on physical medicine, pediatric rehabilitation, and neurorehabilitation at the University of Nis and other institutions.

Work Experience šŸ’¼:

Dr. Hristina Čolović has an extensive career in physical medicine and rehabilitation, spanning over 25 years. She has been a full-time faculty member at the Clinic for Physical Medicine, Rehabilitation, and Prosthetics in Nis, Serbia, since 1995. Starting in 2008, she pioneered the use of botulinum toxin type A in treating children with cerebral palsy, a therapy she has continued to develop and refine. In addition to her clinical practice, Dr. Čolović has served as a professor at the Faculty of Medicine, University of Nis, specializing in physical medicine and rehabilitation, where she trains future healthcare professionals. She has also been a lecturer in pediatric rehabilitation at the College of Health Sciences in Ćupria, Serbia. Dr. Čolovićā€™s career also includes significant involvement in continuing medical education, where she has lectured on topics such as botulinum toxin application and rehabilitation of foot deformities in children.

Awards and HonorsšŸ†

Dr. Hristina Čolović has received numerous awards and honors throughout her distinguished career. She has been recognized for her excellence in both clinical practice and research in the field of physical medicine and rehabilitation. Her contributions to the treatment of children with cerebral palsy using botulinum toxin type A have been particularly noteworthy. In addition to her clinical work, she has earned accolades for her leadership in education and continuous medical training. Dr. Čolovićā€™s research and teaching have been instrumental in advancing pediatric rehabilitation in Serbia and beyond. She has been honored by various medical institutions, including the Serbian Medical Society and the Serbian Medical Chamber. Her role as an invited speaker and lecturer at numerous national and international conferences further highlights her esteemed standing within the medical community. Dr. Čolović’s continued dedication to improving healthcare outcomes, particularly for children with physical disabilities, makes her a respected figure in the field.

Research Focus šŸ”¬:

Dr. Hristina Čolovićā€™s research focuses primarily on pediatric rehabilitation, with a particular emphasis on cerebral palsy and musculoskeletal disorders in children. Her pioneering work on the use of botulinum toxin type A for managing spasticity in children with cerebral palsy has had a significant impact on the field, improving functional outcomes for these children. She is also interested in exploring rehabilitation strategies for other pediatric conditions, such as congenital foot deformities and hip dysplasia. Dr. Čolovićā€™s work involves both clinical applications and functional assessments, aiming to enhance the overall quality of life for children with physical disabilities. Her research contributions include studies on motor activity in premature infants and the effects of rehabilitation interventions on neurological outcomes. Through her research, Dr. Čolović seeks to bridge the gap between innovative treatments and their practical applications in improving the health and mobility of pediatric patients, particularly those with spasticity and developmental disabilities.

šŸ“š Publications

    • A Review of Current Perspectives on Motoric Insufficiency Rehabilitation following Pediatric Stroke
      Authors: Čolović, H., Zlatanović, D., Zivković, V., Jovanović, K., Nikolić, D.
      Citations: 0
      Year: 2024
    • Can pre-treatment dysfunctional voiding and incontinence scoring system score predict treatment outcome in children with dysfunctional voiding ā€“ a randomized trial
      Authors: Živković, V.D., Čolović, H., Zlatanović, D., Vlajković, M.
      Citations: 0
      Year: 2023
    • The importance of assessing general motor activity in premature infants for predicting neurological outcomes
      Authors: Zlatanović, D., Čolović, H., Živković, V., Vučić, J., ToÅ”ić, T.
      Citations: 1
      Year: 2022
    • Factors associated with poor self-reported function and quality of life in patients with end-stage knee or hip osteoarthritis immediately prior to total joint arthroplasty
      Authors: Kocić, M., Milenković, M., Nikolić, D., Čolović, H., Stojanović, Z.
      Citations: 4
      Year: 2021
    • Endometrial immunocompetent cells in proliferative and secretory phase of normal menstrual cycle
      Authors: JanoÅ”evic, D.R., JanoÅ”evic, D.R., Trandafilović, M., Dinic, S.P.-T., Dinic, S.P.-T.
      Citations: 12
      Year: 2020
    • Upper limb robotic neurorehabilitation after pediatric stroke
      Authors: Čolović, H., Dimitrijević, L., Đurić, V., Janković, S.
      Citations: 3
      Year: 2020
    • Botulinum toxin type A for spastic cerebral palsy: Is it time to change praxis?
      Authors: Čolović, H., Dimitrijevic, L., Stanković, I., Radović-JanoÅ”ević, D., Zlatanović, D.
      Citations: 1
      Year: 2020
    • The Role of Early Habilitation in Infants with Congenital Brachial Palsy
      Authors: Živković, V.D., Stanković, I., Dimitrijević, L., Spalević, M., Savić, N.
      Citations: 1
      Year: 2018
    • The effect of physical therapy in the treatment of patients with cervical dystonia with or without concomitant use of botulinum toxin
      Authors: Stanković, I., Čolović, H., Živković, V., Živković, D., Stanković, T.
      Citations: 2
      Year: 2018
    • Chemoinformatic investigation of antibiotic antagonism: The interference of thymus glabrescens essential oil components with the action of streptomycin
      Authors: Ilić, B.S., Miladinović, D.L., Kocić, B.D., Čolović, H., Nikolić, D.M.
      Citations: 3
      Year: 2017

 

ConclusionĀ 

Dr. Hristina Čolovićā€™s profile indicates strong potential for the Robotics Integration Award. Her expertise in physical medicine and rehabilitation, combined with her research into robotic neurorehabilitation, makes her an excellent candidate for recognition. With further development in broader robotics applications and enhanced collaboration with engineers, Dr. Čolović could lead the way in advancing robotic integration into rehabilitation practices, positively impacting patient care across various domains.

 

 

Prof. LindaChao | cognitive neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. LindaChao | cognitive neuroscience | Best Researcher Award šŸ†

Professor/Research Career Scientist at UCSF/San Francisco VA Health Care SystemšŸŽ“

Dr. Linda L. Chao is a highly respected neuroscientist whose journey began with a B.S. in Biological Sciences and a Ph.D. in Neuroscience from UC Davis. Following her postdoctoral training as a Cognitive Neuroscience Fellow at the National Institute of Mental Health, Dr. Chao joined UCSF, where she is now a Professor in Radiology, Psychiatry, and Behavioral Sciences. She also contributes significantly to veteran health research at the San Francisco VA Medical Center. Renowned for her expertise in cognitive neuroscience and neuroimaging, Dr. Chao employs advanced MRI, PET, and fMRI techniques to study neurodegenerative diseases, Gulf War Illness, and PTSD. Her groundbreaking work in non-pharmacological therapies for Alzheimerā€™s and trauma-related conditions has earned her prestigious awards, including the UC Davis Graduate Research Award and the NIMH Fellows Award for Research Excellence. As an active member of key neuroscience organizations and a dedicated mentor, Dr. Chao is a vital figure in advancing mental health research and neuroimaging innovations.

Professional ProfileĀ 

Education šŸŽ“:

Dr. Linda L. Chao earned her B.S. in Biological Sciences (1987-1991) and a Ph.D. in Neuroscience (1991-1996) from the University of California, Davis. Her dedication to understanding the brain and its functions began here, paving the way for her groundbreaking work in neuroscience and cognitive research.

 

Work Experience šŸ’¼:

Dr. Chao’s career reflects a strong commitment to advancing mental health research. Her postdoctoral training took place at the National Institute of Mental Health (NIMH) as a Cognitive Neuroscience Fellow (1996-2000). She joined the University of California, San Francisco (UCSF) as an Assistant Professor in Radiology and Psychiatry in 2001, advancing to Associate Professor and later Professor in the departments of Radiology & Biomedical Imaging, Psychiatry, and Behavioral Sciences. She also holds a significant role with the San Francisco VA Medical Center, where she contributes to research safety and promotes veteran health.

 

Skills šŸ”

Dr. Chao is highly skilled in cognitive neuroscience, neuroimaging, and radiology. She has expertise in analyzing brain health through MRI, PET, and fMRI imaging techniques. Her experience extends to research safety, clinical trials, and therapeutic interventions for neurodegenerative diseases and Gulf War Illness. Her innovative skills in cognitive and neuroimaging research support her work in developing non-pharmacological interventions for conditions like PTSD and Alzheimerā€™s.

 

Awards and Honors šŸ†

Dr. Chaoā€™s research excellence is recognized with numerous awards, including the University of California, Davis Graduate Research Award (1994) and the Fellows Award for Research Excellence from the National Institute of Mental Health (1999). These honors underscore her significant contributions to cognitive neuroscience and clinical research.

 

šŸ¤ Memberships:

Dr. Chao is actively involved in multiple professional organizations, including the Society for Neuroscience (SFN), Cognitive Neuroscience Society (CNS), and the International Society to Advance Alzheimerā€™s Research and Treatment (ISAART). Her memberships reflect her dedication to staying at the forefront of neuroscience, cognitive health, and clinical research.

Teaching Experience šŸ‘©ā€šŸ«:

With a passion for mentoring, Dr. Chao has taught at UCSF’s School of Medicine, facilitating courses on brain, mind, and behavior. She has lectured on clinical fMRI applications and led seminars on neuroimaging. Her role as a mentor has influenced many students and researchers in radiology, psychology, and psychiatry, shaping the future of neuroscience.

 

Research Focus šŸ”¬:

Dr. Chao’s research primarily explores cognitive function, neurodegenerative diseases, and neuroimaging in veterans. Her work on Gulf War Illness and the effects of sarin exposure highlights her commitment to understanding trauma impacts on the brain. Additionally, she investigates photobiomodulation therapies, non-pharmacological dementia treatments, and PTSD interventions. Her recent studies reveal the complex interactions between genetic factors and environmental exposures affecting brain health.

ConclusionĀ 

Dr. Linda L. Chao is a deserving candidate for the Best Researcher Award. Her remarkable contributions to cognitive neuroscience, dedication to mentoring, and commitment to understanding the brain’s response to trauma and neurotoxic exposure make her a vital asset to the field. With her current momentum and slight expansion in her researchā€™s reach and collaboration, Dr. Chao is well-positioned to continue making substantial, globally impactful advancements in neuroscience.

šŸ“š PublilcationĀ 

  • Topic: Implementing a new multidisciplinary, remote, dementia staff training program for Veterans Affairs nursing homes
    • Year: 2024
    • Journal: BMC Health Services Research
  • Topic: Olfactory and cognitive decrements in 1991 Gulf War veterans with Gulf War illness/chronic multisymptom illness
    • Year: 2024
    • Journal: Environmental Health: A Global Access Science Source
  • Topic: Current health status of Gulf War deployed and Gulf War era veterans who use Veterans Affairs health care
    • Year: 2024
    • Journal: Journal of Women’s Health
  • Topic: PON1 status in relation to Gulf War Illness: Evidence of geneā€“exposure interactions from a multisite caseā€“control study of 1990ā€“1991 Gulf War veterans
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Topic: Gulf War illness is associated with host gut microbiome dysbiosis and is linked to altered species abundance in veterans from the BBRAIN cohort
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Topic: Livestream, group movement program for people living with cognitive impairment and care partners: A randomized clinical trial
    • Year: 2024
    • Journal: Alzheimer’s and Dementia: Translational Research and Clinical Interventions
  • Topic: Characterizing 1991 Gulf War women veterans from the Boston Biorepository and Integrative Network for Gulf War Illness: Demographics, exposures, neuroimaging, and cognitive outcomes
    • Year: 2024
    • Journal: Clinical Neuropsychologist
  • Topic: Cognitive decrements in 1991 Gulf War veterans: Associations with Gulf War illness and neurotoxicant exposures in the Boston Biorepository, Recruitment, and Integrative Network (BBRAIN) cohorts
    • Year: 2023
    • Journal: Environmental Health: A Global Access Science Source

 

Prof. Dr. binli | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. Dr. binli | Neuroscience | Best Researcher Award šŸ†

Lecturer (University Professor) at yangzhou university,ChinašŸŽ“

The nominee, a PhD holder in Architecture since 2016, has demonstrated excellence in research, education, and practical applications in architecture and sustainability. His dual focus on comfort and accessibility, alongside nature-based solutions for climate resilience, addresses critical contemporary issues. His notable contributions, backed by research grants and real-world projects, underscore his commitment to advancing sustainable architecture.

 

Professional ProfileĀ 

šŸŽ“ Education

Bin Li earned his Ph.D. in Neuroscience from Nanjing Agricultural University, where his master’s thesis was recognized as an excellent thesis. His educational background laid a strong foundation for his expertise in neuroimmunology and endothelial cell research. šŸŽ“šŸ†

šŸ¢ Work Experience

As a university-appointed professor, Bin has made significant contributions to the field of Neuroscience. His work focuses on the mechanisms of mRNA methylation in endothelial cells and their role in recovery after ischemic stroke, enhancing our understanding of neurovascular repair processes. šŸ§ šŸ„

šŸ§¬ Skills

  • Bin possesses advanced research skills in molecular biology and neuroimmunology, with a strong capability in conducting complex experiments and data analysis. His ability to communicate complex scientific concepts effectively enhances his teaching and mentorship roles. šŸ§ŖšŸ“Š

Awards and Honors šŸ†

He has received numerous accolades, including the “Lv Yang Jin Feng” Outstanding Doctor award and recognition for an outstanding paper at the 19th National Academic Exchange Meeting on Neuropsychopharmacology in 2021. šŸ„‡šŸŽ–ļø

MembershipsšŸ“œĀ 

Bin is an active member of professional organizations, including the Neuroimmunology Branch of the Jiangsu Society of Immunology and the Basic Veterinary Branch of the Jiangsu Animal Husbandry and Veterinary Association, which facilitate collaboration and knowledge exchange in his field. šŸ¤šŸŒ

šŸ“š Teaching Experience

In his role as a lecturer, Bin is dedicated to educating the next generation of scientists, fostering a stimulating learning environment, and guiding students through advanced concepts in Neuroscience and immunology. šŸ“–šŸ‘Øā€šŸ«

šŸ”¬ Research Focus

His current research investigates glial cell-to-neuron and endothelial cell inter-communication during post-ischemic injury, aiming to uncover novel therapeutic strategies for brain recovery. With a total of 12 published papers and significant citations, his research is influential in the field. šŸ”šŸ§¬

ConclusionĀ 

In conclusion, Dr. Bin Li exemplifies the qualities of a leading researcher deserving of the Best Researcher Award. His innovative research, impressive publication record, and active engagement in the scientific community highlight his significant contributions to neuroscience. Addressing the areas for improvement could further amplify his impact, making him a valuable asset to both academia and society. Dr. Li’s commitment to advancing knowledge in neurovascular repair positions him as an outstanding candidate for this prestigious recognition.

šŸ“š PublilcationĀ 

  • EHR coding with hybrid attention and features propagation on disease knowledge graph
    • Year: 2024
    • Journal: Artificial Intelligence in Medicine
  • DAJLENet: A neural network based on dual attention and joint learning for explainable heart failure adverse event prediction
    • Year: 2024
    • Journal: Computers and Electrical Engineering
  • Application programming interface recommendation for smart contract using deep learning from augmented code representation
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process
  • Extraction of Corn Plant Phenotypic Parameters with Keypoint Detection and Stereo Images
    • Year: 2024
    • Journal: Agronomy
  • Ponzi Scheme Detection in Smart Contract via Transaction Semantic Representation Learning
    • Year: 2024
    • Journal: IEEE Transactions on Reliability
  • Normalization of kinship relations to enrich family network analysis: case study on China biographical database
    • Year: 2024
    • Journal: Digital Scholarship in the Humanities
  • Fine-grained smart contract vulnerability detection by heterogeneous code feature learning and automated dataset construction
    • Year: 2024
    • Journal: Journal of Systems and Software
  • Neurodynamics for Equality-Constrained Time-Variant Nonlinear Optimization Using Discretization
    • Year: 2024
    • Journal: IEEE Transactions on Industrial Informatics
  • Automatic software vulnerability classification by extracting vulnerability triggers
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process

 

 

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

MD.,PhD at Ā Medical University of Lublin , Poland

Dr. Ryszard Pluta is a distinguished neurologist and neuroscientist, with a medical degree from the Medical Academy in Lublin (1977) and a Ph.D. from the Polish Academy of Sciences (1983). He has served as a Professor at the Mossakowski Medical Research Institute and held prestigious postdoctoral fellowships at the NIH and NYS Institute for Basic Research. A recognized expert in brain ischemia and Alzheimer’s disease, Dr. Pluta has published extensively, including multiple influential books on the subject. He is a recipient of numerous awards and is an active member of several professional societies. His significant contributions to understanding the links between ischemia and Alzheimer’s have established him as a leading figure in neuropathology.

Profile:

ScopusĀ 

Education šŸŽ“

Ryszard Pluta earned his medical degree from the Medical Academy in Lublin (1971-1977) and attended Humboldt University in Berlin (1975) and the University of Cologne (1976). He completed his Ph.D. at the Polish Academy of Sciences in Warsaw (1983). He became an Associated Professor in 1992 and a full Professor in 2004 at the Mossakowski Medical Research Institute, Polish Academy of Sciences.

Work Experience šŸ’¼

Dr. Pluta has held prestigious positions, including postdoctoral fellowships at the NIH in Bethesda, USA (1986-1988), and the NYS Institute for Basic Research in New York (1988-1989). He has been a Visiting Professor at several renowned institutions, including the Max-Planck Institute for Neurological Research and Charles University in Prague.

Skills šŸ§ 

With extensive expertise in neuropathology and neurochemistry, Dr. Pluta specializes in brain ischemia and Alzheimer’s disease research. His skills encompass project management, collaboration with international research teams, and contributions to clinical studies in the field of neuroscience.

Awards and Honors šŸ†

Dr. Pluta has received numerous accolades, including recognition from the Polish Association of Neuropathologists (1980, 1986) and the Polish Academy of Sciences (1982, 1989, 1992). He was also honored by the International Brain Research Organization (1997) and the Alzheimerā€™s Association in Chicago (1998).

Membership šŸ¤

He is an active member of various professional organizations, including the Polish Association of Neuropathologists and the International Society of Neuropathology. Dr. Pluta is recognized among the World’s Top 2% scientists by Stanford University.

Teaching Experience šŸ“š

Dr. Pluta has contributed to the academic community through teaching positions at various universities, where he has shared his knowledge and expertise in neuropathology and neuroscience with students and researchers.

Research Focus šŸ”¬

His research focuses on brain ischemia, its relationship with Alzheimer’s disease, and associated neuropathological changes. He has made significant contributions, such as the documentation of identical changes in ischemic brains and those affected by Alzheimer’s, and the exploration of potential therapeutic approaches involving Ī²-amyloid peptide.

 

Publications:

  • Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer’s Disease with Survival up to 2 Years
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Trans- and Cis-Phosphorylated Tau Protein: New Pieces of the Puzzle in the Development of Neurofibrillary Tangles in Post-Ischemic Brain Neurodegeneration of the Alzheimerā€™s Disease-like Type
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • A Look at the Etiology of Alzheimer’s Disease based on the Brain Ischemia Model
    • Year: 2024
    • Journal: Current Alzheimer Research
  • Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Ischemia-Reperfusion Programming of Alzheimerā€™s Disease-Related Genesā€”A New Perspective on Brain Neurodegeneration after Cardiac Arrest
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimerā€™s Disease with 2-Year Survival
    • Year: 2023
    • Journal: Cells
  • The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimerā€™s Disease Proteinopathy
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Preservation of Biomarkers Associated with Alzheimerā€™s Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimerā€™s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
    • Year: 2023
    • Journal: Molecules
  • Post-Ischemic Permeability of the Bloodā€“Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimerā€™s Disease-Type Brain Neurodegeneration
    • Year: 2023
    • Journal: International Journal of Molecular Sciences

Dr. Amira Boseila | Neuroscience| Best Researcher Award

Posted on by sciencefather

Dr. Amira Boseila | Neuroscience| Best Researcher AwardšŸ†


Lecturer at Sinai University,EgyptšŸŽ“

Dr. Amira Abdel Halim Hamada Boseila is a full-time lecturer in Pharmaceutical Sciences at Sinai University, Egypt, where she teaches advanced courses in drug delivery systems and pharmaceutics. She also serves as a post-doctoral researcher at the National Organization for Drug Control and Research (NODCAR) and the Egyptian Drug Authority. With a PhD from Cairo University, her research focuses on nanomedicine, drug targeting, and innovative drug delivery systems. Dr. Boseila has contributed to several impactful publications and is actively involved in various research projects aimed at enhancing therapeutic strategies.

 

Professional ProfileĀ 

šŸŽ“ Education

Dr. Amira Abdel Halim Hamada Boseila holds a Doctor of Philosophy in Pharmaceutical Sciences from the Faculty of Pharmacy at Cairo University, awarded in February 2020, with a thesis focused on the utility of nanocarriers for targeted delivery of an antiviral drug to the liver. She also earned a Master of Pharmaceutical Sciences from Cairo University in December 2013, where her thesis was centered on the formulation and evaluation of a modified nasal drug delivery system for the antiemetic drug ondansetron. Additionally, she completed a Total Quality Management Diploma at the American University of Cairo in 2009, further enhancing her expertise in quality control management. Her academic journey began with a Bachelor of Pharmaceutical Sciences from Cairo University, graduating in May 2007 with a grade of very good. She attended La Rose De Lisieux/Language School in Dokkie, where she completed her high school education with a focus on science from September 1990 to June 2002.

 

šŸ¢ Work Experience

Full-time lecturer at the Faculty of Pharmacy, Sinai University since September 2022, and post-doctoral researcher at NODCAR and the Egyptian Drug Authority since July 2020. Previously held positions as lead quality control specialist and head of the Comparative Dissolution Unit. Guest lecturer on drug targeting at Ain Shams University since October 2020

šŸ§¬ Skills

Expertise in novel drug delivery systems, nanomedicine, drug targeting, pharmacokinetics, comparative dissolution studies, and quality by design

Awards and Honors šŸ†

Recognized for contributions to pharmaceutical research through impactful publications and ongoing collaborations with prestigious institutions, including funded research projects from the University of Hail and Misr El Kheir Foundation

šŸ”¬ Research Focus

Dedicated to advancing nanomedicine and innovative drug delivery systems, with a focus on developing targeted therapies and modified release dosage forms. Actively involved in projects aimed at repurposing anti-inflammatory agents and formulating virucidal throat sprays

šŸ“š PublicationĀ 

  • Impact of Lyophilized Milk Kefir-Based Self-Nanoemulsifying System on Cognitive Enhancement via the Microbiotaā€“Gutā€“Brain Axis
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Throat Spray Formulated with Virucidal Pharmaceutical Excipients as an Effective Early Prophylactic or Treatment Strategy Against Pharyngitis Post-Exposure to SARS-CoV-2
    Author: Amira Boseila
    Citation: ScienceDirect, 2024
  • Antidepressive and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum Perforatum on Post-Myocardial Infarction Depression in Rats
    Author: Amira Boseila
    Citation: Springer, 2022
  • Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Iron Oxide Nanoparticles-Plant Insignia Synthesis with Favorable Biomedical Activities and Less Toxicity, in the ā€œEra of the-Greenā€: A Systematic Review
    Author: Amira Boseila
    Citation: NIH, 2023
  • In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir
    Author: Amira Boseila
    Citation: Molecular Pharmaceutics, 2023
  • Design of Bile-Based Vesicles (BBVs) for Hepatocytes Specific Delivery of Daclatasvir: Comparison of Ex-Vivo Transenterocytic Transport, In-Vitro Protein Adsorption Resistance, and HepG2 Cellular Uptake of Charged and Ī²-Sitosterol Decorated Vesicles
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Preparation and Characterization of Thermosensitive Mucoadhesive In-Situ Gels for Nasal Delivery of Ondansetron Hydrochloride
    Authors: A.A. Boseila, A.Y. Abdel-Reheem, G. Abdelbary
    Citation: Al-Azhar Journal of Pharmaceutical Sciences, 2014

 

Dr NISHI PATEL | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr NISHI PATEL | Neuroscience | Best Researcher AwardĀ Ā  šŸ†

Research Scholar at Bhagwan Mahavir University, Surat , IndiašŸŽ“

Dr. Nishi Jayesh Patel is a dedicated research scholar at Bhagwan Mahavir University, specializing in the study of Parkinson’s Disease šŸ§ . With over four years of significant contributions in this field, she has become an expert in neurodegenerative disorders, particularly focusing on microbiology and probiotics. Dr. Patel has published research on the relationship between gut microflora and Parkinsonā€™s, exploring innovative treatments such as in-vitro probiotic formulations. She is also a member of the Parkinson’s Foundation, continually striving to advance knowledge and treatment for the disease.

 

Professional ProfileĀ 

  • Google ScholarĀ 

Education šŸŽ“

Dr. Patel holds advanced degrees in microbiology and neurological sciences, fueling her passion for neurodegenerative disease research. Her academic excellence and thorough understanding of Parkinson’s Disease enable her to make meaningful strides in the field.

Work Experience šŸ¢

Apart from her research work, Dr. Patel is a seasoned subject matter expert and has contributed significantly to academic assessment by setting papers for national and international entrance exams. Her work in this area has helped shape the academic landscape and ensure high standards for future medical professionals.

Awards and Honors šŸ†

While specific awards are not mentioned, Dr. Patelā€™sĀ numerous professional contributions, including her membership in the Parkinson’s Foundation, speak to her dedication and excellence in the field of medical research.

Research Focus šŸ”

Dr. Patelā€™s core research focuses on probiotics and their role in neurological disorders. She has identified six bacterial strains that are potential candidates for therapeutic use in Parkinsonā€™s Disease, with promising results in balancing GABA collapse, improving drug bioavailability, and controlling disease progression. These isolates show potential in controlling mood, immunity, and digestion, positively influencing patients’ well-being.

 

 

Publications :Ā 

  • Evaluating Probiotic Properties of Gut Microflora for Gut Modulation as an Adjuvant Therapy for Parkinson’s Disease
    Authors: NJ Patel, M Hajoori
    Journal: Journal of Future Foods
    Year: 2025
    Volume: 5
    Issue: 3
    Pages: 304-316
  • Isolation, Characterisation, and Screening of Gut Bacteria for Essential Probiotic Characteristics
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: European Journal of Biomedical and Pharmaceutical Sciences
    Year: 2023
    Volume: 10
    Issue: 11
    Pages: 176-179
  • Comparative Formulation and Evaluation of Probiotic Products Utilizing Different Bacterial Strains: A Comprehensive Study
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Biological Forum ā€“ An International Journal
    Year: 2023
    Volume: 15
    Issue: 5
    Pages: 1747-1752
  • Psychobiotics: The Next Generation Adjuvant Therapy and Its Revolutionary Contribution in Treatment for Parkinsonā€™s Disease
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Futuristic Trends in Medical Sciences
    Year: 2022
    Book: 21, Part 1
    Pages: 1-15
  • Bioremediation of Surfactants by Bacteria Isolated from Spume Used to Scavenge Surfactants Along with Dyes in Washing Textile Effluents
    Author: DRD Nishi Jayesh Patel
    Journal: JETIR Research Journal
    Year: 2020
    Volume: 7
    Issue: 6
    Pages: 1147-1153

 

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award šŸ†

Division of Diabetes and Nutrition at RARiS, Tohoku University,Ā Japan
šŸŽ“

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional ProfileĀ 

šŸ“š Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

šŸŽ–ļø Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

šŸŒ Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofengā€™s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications :Ā 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences